ATS 2019 Virtual Final Program

ATS 2019 • Dallas, TX 372 WEDNESDAY • MAY 22 2:30 Management of Mechanical Ventilation 2019 N. Qadir, MD, Los Angeles, CA 3:00 Neuromuscular Respiratory Failure D.C. Files, MD, Winston-Salem, NC CLINICAL CLINICAL TOPICS IN PULMONARY MEDICINE CME Credits Available: 2 D82 AUTOIMMUNE ASSOCIATED ILD: A CASE BASED APPROACH TO DIAGNOSIS AND TREATMENT Assembly on Clinical Problems 1:30 p.m. - 3:30 p.m. KBHCCD Ballroom C One-Two (Level 2) Target Audience Community pulmonologists and academic physicians with varying levels of interest and expertise in ILD Objectives At the conclusion of this session, the participant will be able to: • understand the significance of positive autoimmune serologies and the utility of obtaining a lung biopsy in the context of different ILD patterns; • utilize alternative diagnostic and therapeutic approaches to ILD patients within their local practice, thus improving outcomes for challenging cases; • identify and manage comorbidities associated with ILD. This will ultimately improve outcomes of their local patient population. This session will facilitate an interactive and multidisciplinary discussion about challenging topics related to the diagnosis and management of autoimmune ILD: Interpretation of serologies and physical findings; The utility of a surgical biopsy; choosing an appropriate therapeutic agent; and managing comorbidities that accompany ILD. For each topic, a multiple-choice question will be presented with electronic polling of the audience and an expert panel comprised of pulmonologists, a radiologist, pathologist, and rheumatologist. An expert will then present formally on each topic, and the audience will be polled again to determine if the discussion has changed their responses. Chairing: R. Hallowell, MD, Boston, MA S.K. Danoff, MD, PhD, Baltimore, MD L.L. Silhan, MD, Dallas, TX T.J. Corte, MBBS, BScM, PhD, Sydney, Australia 1:30 Introduction R. Hallowell, MD, Boston, MA 1:33 Case Presentation Part 1 R. Hallowell, MD, Boston, MA 1:35 Audience Question #1 R. Hallowell, MD, Boston, MA 1:36 How to Approach My ILD Patient With a Positive Autoimmune Serology? R. Vij, MD, Chicago, IL 1:56 Case Presentation Part 2 L.L. Silhan, MD, Dallas, TX 1:58 Expert CT Scan Interpretation in This Patient With ILD S. Hobbs, MD, Lexington, KY 2:08 Audience Question #2 L.L. Silhan, MD, Dallas, TX 2:09 Lung Biopsy in CTD-ILD: A Crazy Idea or Sometimes Worth the Risk? V. Cottin, PhD, MD, Lyon, France 2:29 Pathologic Findings in CTD-ILD P. Vanderlaan, MD, PhD, Boston, MA 2:39 Case Presentation Part 3 T.J. Corte, MBBS, BScM, PhD, Sydney, Australia 2:41 Audience Question #3 T.J. Corte, MBBS, BScM, PhD, Sydney, Australia 2:42 How Do I Choose an Immunosuppressive Regimen in My Patient With CTD-ILD? K.B. Highland, MD, Cleveland, OH 3:02 Case Presentation Part 4 S.K. Danoff, MD, PhD, Baltimore, MD 3:04 Audience Question #4 S.K. Danoff, MD, PhD, Baltimore, MD 3:05 Managing Comorbidities in Patients with ILD J. Oldham, MD, MS, Sacramento, CA 3:25 Brief Conclusions and Questions From the Audience R. Hallowell, MD, Boston, MA This session and the International Conference are supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., Genentech, Inc. All CME sessions have been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) and are free of the control of commercial interests. CLINICAL CLINICAL TOPICS IN PULMONARY MEDICINE CME Credits Available: 2 D83 NEW ADVANCES IN THE BRONCHOSCOPIC DIAGNOSIS AND TREATMENT OF LUNG CANCER Assemblies on Clinical Problems; Nursing; Respiratory Structure and Function; Thoracic Oncology; 1:30 p.m. - 3:30 p.m. KBHCCD Ballroom C Three-Four (Level 2) Target Audience Clinicians, researchers, fellows in training, nurses and therapists who care for patients with lung cancer or solitary pulmonary nodules Objectives At the conclusion of this session, the participant will be able to: • become aware of the new bronchoscopic techniques that are capable of diagnosing and assessing staging of lung cancer; • gain understanding of new bronchoscopic techniques that may have potential to treat early-stage lung cancer; • understand the importance of comorbid lung diseases in the diagnosis and management of patients that present with solitary pulmonary nodules that may be lung cancer.